Reynolds, Ann M. http://orcid.org/0000-0002-0836-746X
Soke, Gnakub N.
Sabourin, Katherine R.
Croen, Lisa A.
Daniels, Julie L.
Fallin, M. Daniele
Kral, Tanja V. E.
Lee, Li- Ching
Newschaffer, Craig J.
Pinto-Martin, Jennifer A.
Schieve, Laura A.
Sims, Amy
Wiggins, Lisa
Levy, Susan E.
Funding for this research was provided by:
National Center on Birth Defects and Developmental Disabilities (01086, 02199, DD11-002, DD06-003, DD04-001, and DD09-002)
National Center for Advancing Translational Sciences (UL1TR001082)
Article History
Accepted: 5 November 2020
First Online: 4 January 2021
Compliance with Ethical Standards
:
: The authors have no conflicts of interest relevant to this article to disclose. Dr. Reynolds is participating in clinical trials with Roche and is providing consultation to Ovid Therapeutics regarding evaluation of sleep severity and improvement in clinical trials.